People living with HIV on modern antiretroviral therapy now experience obesity rates matching the general population, creating a new clinical challenge as this population ages. The research reveals that obesity in HIV patients directly drives metabolic dysfunction beyond what's typically seen, suggesting HIV-specific pathways amplify obesity's harmful effects. This represents a dramatic shift from the historical wasting syndrome associated with untreated HIV. The convergence of HIV and obesity creates a perfect storm for cardiovascular disease, diabetes, and other age-related conditions in a population already facing immune system challenges. While lifestyle interventions remain important, the review emphasizes that surgical and pharmacological weight loss treatments show superior efficacy in reducing obesity-related complications. This finding challenges the traditional focus on nutritional support in HIV care, suggesting aggressive weight management may now be as critical as viral suppression. The research highlights a paradigm shift in HIV medicine from managing undernutrition to confronting obesity—a testament to treatment success but also an emerging threat requiring specialized clinical approaches for this vulnerable aging population.